Clarification of anticholinergic effects of quetiapine.
Goldstein
J M
JM
Brecher
M
M
D000368:Aged; D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D003987:Dibenzothiazepines / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D051379:Mice; D000069348:Quetiapine Fumarate; D011950:Receptors, Cholinergic / Q000187:drug effects; D011976:Receptors, Muscarinic / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy
D014150:Antipsychotic Agents; D018680:Cholinergic Antagonists; D003987:Dibenzothiazepines; D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; D000069348:Quetiapine Fumarate